|
ANKIB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64102065269844E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.2712053631958E-13 |
| Normal-vs-Stage2 |
7.574200E-04 |
| Normal-vs-Stage3 |
2.69809730113479E-11 |
| Normal-vs-Stage4 |
2.8421709430404E-14 |
| Stage1-vs-Stage2 |
7.772100E-02 |
| Stage1-vs-Stage3 |
1.752570E-01 |
| Stage1-vs-Stage4 |
1.539430E-03 |
| Stage2-vs-Stage3 |
1.451820E-02 |
| Stage2-vs-Stage4 |
6.386300E-04 |
| Stage3-vs-Stage4 |
1.139840E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.55431223447522E-14 |
| Normal-vs-AfricanAmerican |
3.3745000005414E-07 |
| Normal-vs-Asian |
5.4870996635259E-10 |
| Caucasian-vs-AfricanAmerican |
8.012800E-01 |
| Caucasian-vs-Asian |
7.897200E-01 |
| AfricanAmerican-vs-Asian |
9.304200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.33171251803788E-12 |
| Normal-vs-Female |
1.96354044135205E-12 |
| Male-vs-Female |
4.120400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.86070048258102E-11 |
| Normal-vs-Age(41-60Yrs) |
1.49946721705874E-12 |
| Normal-vs-Age(61-80Yrs) |
6.62079946422978E-10 |
| Normal-vs-Age(81-100Yrs) |
6.043900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.968800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.756600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.096400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.732600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.270200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.502400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.822160E-01 |
| Classical-VS-Follicular |
5.981500E-02 |
| Classical-VS-Other |
7.216800E-01 |
| Classical-VS-Normal |
1.63713487211226E-12 |
| Tall-VS-Follicular |
1.183640E-02 |
| Tall-VS-Other |
7.373600E-01 |
| Tall-VS-Normal |
5.86979997940773E-09 |
| Follicular-VS-Other |
3.900600E-01 |
| Follicular-VS-Normal |
3.78600000000562E-05 |
| Other-VS-Normal |
2.240900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.35599983966495E-10 |
| Normal-vs-N1 |
5.54079004899677E-12 |
| N0-vs-N1 |
5.031900E-02 |
|
|
